Abstract
Ease of access to the cornea makes antimicrobial peptides (AMPs) ideal candidates for topical drug application. However, before bringing them to the clinic, it is fundamental to evaluate in vitro: (1) the ability of AMPs to kill bacteria in the presence of human tears, by counting the number of surviving bacteria on agar plates; (2) the potential cytotoxicity of AMPs to mammalian cells by a colorimetric method based on the production of a colored formazan crystals by metabolically active cells; and (3) the ability of AMPs to neutralize the toxic effect of the bacterial cell wall component, lipopolysaccharide (LPS), by measuring the level of the pro-inflammatory cytokine, TNF-α, released from LPS-activated macrophages, using a sandwich enzyme-linked immunosorbent assay.
Original language | English |
---|---|
Title of host publication | Antimicrobial Peptides |
Editors | Paul Hansen |
Place of Publication | London |
Publisher | Springer |
Pages | 395-409 |
Volume | 1548 |
ISBN (Print) | 978-1-4939-6735-3 |
DOIs | |
Publication status | Published - 25 Dec 2016 |
Keywords
- Colony counts
- Tear collection
- Colorimetric MTT assay
- Sandwich immunosorbent assay
- LPS detoxification